Abstract
Human recombinant interferon alpha A/D (αA/D) was examined for its antitumor activity in several mouse tumor models using metastatic tumors, such as B16 melanoma F1, BL6 and F10, UV2237m fibrosarcoma, and K1735m melanoma. Therapeutic treatment with αA/D reduced the incidence of pulmonary metastasis and inhibited the tumor growth resulting in an increase of the mean survival time. Since αA/D also showed a prophylactic activity against the metastasis, its antitumor activity was suggested to be due to augmentation of the host defense systems. This was confirmed by the fact that αA/D inhibited thein vivo growth and incidence of pulmonary metastasis of B16 F1 sublines regardless of their sensitivity to the direct antiproliferative activity of the IFNin vitro.
Similar content being viewed by others
References
Balkwill, F., Taylor-Papadimitriou, J., Fantes, K. H., andSebesteny, A., 1980, Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice.European Journal of Cancer,16, 569–573.
Barlozzari, T., Leonhardt, J., Wiltrout, R. H., Herberman, R. B., andReynolds, C. W., 1985, Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.Journal of Immunology,134, 2783–2789.
Belardelli, F., Gresser, I., Maury, C., andMaunoury, M. T., 1982, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.International Journal of Cancer,30, 813–820.
Belardelli, F., Gresser, I., Maury, C., andMaunoury, M. T., 1982, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanism.International Journal of Cancer,30, 821–825.
Brouty-Boye, D., 1980, Inhibitory effects of interferons on cell multiplication.Lymphokine Reports, Vol. 1, edited by E. Pick (New York: Academic Press), pp. 99–112.
Brunda, M. J., Rosenbaum, D., andStern, L., 1984, Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: Correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.International Journal of Cancer,34, 421–426.
Brunda, M. J., andRosenbaum, D., 1984, Modulation of murine natural killer cell activityin vitro andin vivo by recombinant human interferons.Cancer Research,44, 597–601.
Goeddel, D. V., Yelverton, E., Ullrich, A., Heyneker, H. L., Miozzari, G., Holmes, W., Seeburg, P. H., Dull, T., May, L., Stebbing, N., Crea, R., Maeda, S., McCandliss, R., Sloma, A., Tabor, J. M., Gross, M., Familletti, P. C., andPestka, S., 1980, Human leukocyte interferon produced byE. coli is biologically active.Nature,287, 411–416.
Gresser, I., Brouty-Boye, D., Thomas, M. T., andMacieira-Coelho, A., 1970, Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L1210 cellsin vitro by interferon preparations.Proceedings of the National Academy of Sciences, U.S.A.,66, 1052–1058.
Gresser, I., Maury, C., andBrouty-Boye, D., 1972, Mechanism of the antitumor effect of interferon in mice.Nature,239, 167–168.
Gresser, I., andTovey, M. G., 1978, Antitumor effects of interferon.Biochimica Biophysica Acta,516, 231–247.
Kataoka, T., Matsuura, N., Oh-hashi, F., andSuhara, Y., 1985, Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.Cancer Research,45, 3548–3553.
Kimura, K., 1983, Overview of phase II study of human lymphoblastoid interferon (HLBI) for solid tumor and blood cancer in Japan.Interferons: Proceedings of the International Symposium on Interferon, edited by T. Kishida (Ohsaka: Japan Convention Service), pp. 157–162.
Kramer, M. J., Dennin, R., Kramer, C., Jones, G., Connell, E., Rolon, N., Gruarin, A., Kale, R., andTrown, P. W., 1983, Cell and virus sensitivity studies with recombinant human alpha interferon.Journal of Interferon Research,3, 425–435.
Lee, S. H., Chiu, H., Rinderknecht, E., Sabo, W., andStebbing, N., 1983, Importance of treatment regimen of interferon as an antitumor agent.Cancer Research,43, 4172–4175.
Minato, N., Reid, L., Cantor, H., Lengyel, P., andBloom, B. R., 1980, Mode of regulation of natural killer cell activity by interferon.Journal of Experimental Medicine,152, 124–137.
Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Escödi, J., Boll, W., Canntell, K., andWeissman, C., 1980, Synthesis inE. coli of a polypeptide with human leukocyte interferon activity.Nature,284, 316–320.
Nishimura, J.,Mitsui, K., andIshitsuka, H., 1984, Antitumor activity of human recombinant IFN alpha A/D against B16 melanoma.Proceedings of the Japanese Cancer Association, The 43rd Annual Meeting, 1141.
Rehberg, E., Kelder, B., Hoal, E. G., andPestka, S., 1982, Specific molecular activities of recombinant and hybrid leukocyte interferons.Journal of Biological Chemistry,257, 11497–11502.
Reid, L. M., Minato, N., Gresser, I., Holland, J., Kadish, A., andBloom, B. R., 1981, Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and human prostatic tumors in athymic nude mice.Proceedings of the National Academy of Sciences, U.S.A.,78, 1171–1175.
Rubinstein, S., Familletti, P. C., andPestka, S., 1981, Convenient assay for interferons.Journal of Virology,37, 755–758.
Sonnenfeld, G., 1980, Modulation of immunity by interferon.Lymphokine Reports, Vol. 1, edited by E. Pick (New York: Academic Press), pp. 113–131.
Staehelin, T., Hobbs, D. S., Kung, H.-F., Lai, C.-Y., andPestka, S., 1981, Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies.Journal of Biological Chemistry,256, 9750–9754.
Taguchi, T., Takakura, K., Kimura, K., Ohta, K., Izuo, M., Koyama, Y., Niijima, T., Ikeda, S., andAkahoshi, Y., 1983, Clinical studies of recombinant leukocyte A interferon (rIFN-alpha A).Interferons: Proceedings of International Symposium on Interferon, edited by T. Kishida (Ohsaka: Japan Convention Service), pp. 173–180.
Uno, K., Shimizu, S., Ido, M., Naito, K., Inaba, K., Oku, T., Kishida, T., andMuramatsu, S., 1985, Direct and indirect effects of interferon onin vivo murine tumor cell growth.Cancer Research,45, 1320–1327.
Weck, P. K., Rinderknecht, E., Estell, D. A., andStebbing, N., 1982, Antiviral activity of bacteria derived human alpha interferons against encephalomyocarditis virus infection of mice.Infection and Immunity,35, 660–665.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishimura, J., Mitsui, K., Ishikawa, T. et al. Antitumor and antimetastatic activities of human recombinant interferon alpha A/D. Clin Exp Metast 3, 295–304 (1985). https://doi.org/10.1007/BF01585083
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01585083